Clinical Trials Directory

Trials / Completed

CompletedNCT00080171

Osteoarthritis Initiative (OAI): A Knee Health Study

Status
Completed
Phase
Study type
Observational
Enrollment
4,796 (actual)
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · NIH
Sex
All
Age
45 Years – 79 Years
Healthy volunteers
Accepted

Summary

Knee osteoarthritis (OA) is the most common cause of disability in adults. The "Osteoarthritis Initiative (OAI): A Knee Health Study" is a nationwide research study that will help researchers gather more information about the physical changes that occur prior to the onset of arthritis symptoms or before OA gets worse. The purpose of this study is to examine people who have knee OA or are at high risk for knee OA; information will be used to better understand how to prevent and treat knee OA.

Detailed description

Knee OA causes more health problems and medical expenses that any other form of arthritis. Symptoms of OA can range from stiffness and mild pain to severe joint pain and even disability. Previous research has shown that certain factors, such as knee pain, prior knee injury or knee surgery, OA of the hand, or obesity, may lead to knee OA. The OAI is a multicenter, observational study of knee OA that will collect information on potential biomarkers for OA and trends in OA onset and progression. The OAI will recruit and follow participants who have knee OA or are at high risk for developing knee OA for an eight-year period at one of four clinical centers. Blood and urine collection, magnetic resonance imaging (MRI), and X-rays will be completed at each of four annual follow-up visits. A questionnaire and physical examination at screening will assess for risk factors for the development and progression of knee OA. Levels of knee pain and physical disability will be assessed at study start and at each of the follow-up visits by questionnaire and examination.

Conditions

Timeline

Start date
2004-02-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2004-03-25
Last updated
2020-09-29

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00080171. Inclusion in this directory is not an endorsement.